Kyverna Therapeutics, Inc. (KYTX) Form 10-Q Quarterly Reports
Kyverna Therapeutics, Inc. (KYTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KYTX
CIK: 1994702
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerBo-Reum Monaco
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001193125-26-400062 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-350332 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344607 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344572 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002893 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-23 | 8-K | 0001193125-26-316916 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-08 | 8-K | 0001193125-26-298979 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-05-27 | 8-K | 0001193125-26-253604 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 | 0001193125-26-248435 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 | 0001193125-26-248434 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 | 0001193125-26-248429 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 | 0001193125-26-248427 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 | 0001193125-26-248425 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | 4 | 0001193125-26-232681 | View SEC Doc Filr Page |
| 3 | 2026-05-20 | 2026-05-18 | 3 | 0001193125-26-232683 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-14 | 8-K | 0001193125-26-227920 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219397 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-219377 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209120 | View SEC Doc Filr Page |
| 3 | 2026-05-06 | 2026-05-04 | 3 | 0001193125-26-209119 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001193125-26-202610 | View SEC Doc Filr Page |
| 8-K | 2026-04-22 | 2026-04-22 | 8-K | 0001193125-26-168287 | View SEC Doc Filr Page |
| 8-K | 2026-04-22 | 2026-04-21 | 8-K | 0001193125-26-167512 | View SEC Doc Filr Page |
| 8-K | 2026-04-20 | 2026-04-20 | 8-K | 0001193125-26-162755 | View SEC Doc Filr Page |
| 144 | 2026-04-17 | — | 144 Filing | 0001950047-26-003607 | View SEC Doc Filr Page |